Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic

The treatment of progressive multiple sclerosis (MS) is unsatisfactory. One reason is that the drivers of disease, which include iron-mediated neurotoxicity, lymphocyte activity, and oxidative stress, are not simultaneously targeted. Here we present a systematic screen to identify generic, orally av...

Descripción completa

Detalles Bibliográficos
Autores principales: Faissner, Simon, Mishra, Manoj, Kaushik, Deepak K., Wang, Jianxiong, Fan, Yan, Silva, Claudia, Rauw, Gail, Metz, Luanne, Koch, Marcus, Yong, V. Wee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736601/
https://www.ncbi.nlm.nih.gov/pubmed/29259169
http://dx.doi.org/10.1038/s41467-017-02119-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736601/
https://www.ncbi.nlm.nih.gov/pubmed/29259169
http://dx.doi.org/10.1038/s41467-017-02119-6

Ejemplares similares